Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups ...
Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback